ACHIEVE
People on dialysis face a high risk of heart-related death. BHF funding helped the UK join a global trial testing if the drug spironolactone can reduce this risk.
Impact of clinical trials: prevention
BHF is driving prevention-focused research, testing new ways to protect people at risk of heart and blood vessel problems.
Our completed trials
AdDIT
AdDIT tested if giving young people with type 1 diabetes medicine to lower blood pressure and cholesterol can help stop heart and kidney problems.
ASCEND
People with diabetes were asked to take a daily aspirin tablet or fish oil capsule, or both, to see if this helped prevent heart attacks and strokes.
FIREPROOF
Cardiovascular events, such as heart attacks, are the main cause of death among on duty firefighters. FIREPROOF explored the reasons behind this.
RRT
Researchers carried out the RRT study to identify how best to help people quit smoking successfully.
SAMSON
This trial allowed people to assess for themselves whether taking a statin was the cause of their side effects.
SHARP
SHARP tested whether cholesterol lowering drugs can prevent heart and circulatory disease in people with chronic kidney disease.
VESUVIUS
VESUVIUS looked at whether vaping is better for cardiovascular health than smoking. It tested the short term effects of e cigarettes on blood vessels.